Rubius Therapeutics Inc (NASDAQ:RUBY)

0.2804
Delayed Data
As of 3:59pm ET
 -0.0135 / -4.59%
Today’s Change
0.14
Today|||52-Week Range
6.54
+60.23%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Epstein David R
Director
Buy4/21/202230,000$1.44$43.2K-78.42%
Appelhans Dannielle
Chief Operating Officer
Sale8/10/20225,737$0.80$4.6K-64.73%
Cagnoni Pablo J
Director
Sale2/01/20238,448$0.25$2.1K+3.11%
Cagnoni Pablo J
Director
Sale1/31/20237,240$0.24$1.7K+6.87%
Appelhans Dannielle
President & Chief Executive Officer
Sale2/01/20233,878$0.25$969.50+3.11%
Turka Laurence
Chief Scientific Officer
Sale1/31/20232,593$0.24$622.32+6.87%
Turka Laurence
Chief Scientific Officer
Buy1/29/20237,438$0.00$0.00+9.61%
Turka Laurence
Chief Scientific Officer
Buy1/31/20238,625$0.00$0.00+6.87%
Cagnoni Pablo J
Director
Buy1/29/202321,250$0.00$0.00+9.61%
Cagnoni Pablo J
Director
Buy1/31/202325,000$0.00$0.00+6.87%
Page of 2